Company / Return on Equity (ROE)
Bausch & Lomb Corp Return on Equity (ROE) History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Equity (ROE)
-5.6%
FY2025
5-year range
-5.6% / 1.9%
FY2021-FY2025
Trend
-13.9%
vs FY2024
Sector context
#100 of 147
Health Care
What the data says
Bausch & Lomb Corp reports negative total equity of -5.6% in FY2025. Negative equity can occur when accumulated losses exceed contributed capital, as reported in the balance sheet from the SEC filing.
Based on SEC 10-K filings.
-5.6% in FY2025 with a 5-year CAGR of -5.4%.
Declined from -3.8% to -5.6% over the past 2 years.
Health Care sector context is included.
Return on Equity (ROE) over time
Growth rates
- 3-Year Change
- -5.7pp
- 5-Year Change
- -5.4pp
- 10-Year Change
- -
Sector benchmark
#100 of 147 in Health CareTop 68% of 147This company -5.6% Sector average -3.1%
▼
-78.8% below sector average
Key checks
Key Insights
- Bausch & Lomb Corp's return on equity (roe) has declined for 4 consecutive years.
- In FY2025, return on equity (roe) decreased 13.9% year-over-year.
- Currently 2.5pp below the Health Care sector average.
- Peak return on equity (roe) was recorded in FY2021.
Company context
Key Data Points
- Altman Z-Score 0.74 (distress zone, below 1.8 threshold)
- Negative profit margin: -6.6%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Equity (ROE)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -5.6% | -13.9% |
| FY2024 | -4.9% | -28.9% |
| FY2023 | -3.8% | -4322.2% |
| FY2022 | 0.1% | -95.4% |
| FY2021 | 1.9% | +1177.8% |
| FY2020 | -0.2% | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026